Dubensky Thomas W. Insider Trades

Insider Trading History

Track insider trading activity for Dubensky Thomas W.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Tempest Therapeutics
Tempest Therapeutics TPST
President
Holding Value $134k 102,700 shares
Last Trade
Jan 03, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.64M 102,700 shares
$15.99
$1.30
HTG Molecular Diagnostics
HTG Molecular Diagnostics HTGM
Director
Holding Value $3.84k 8,000 shares
Last Trade
Aug 18, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$90.4k 8,000 shares
$11.30
$0.48
Tempest Therapeutics
Tempest Therapeutics TPST
President
Holding Value $114k 87,801 shares
Last Trade
Jun 21, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$206k 87,801 shares
$2.35
$1.30
Millendo Therapeutics
Millendo Therapeutics MLND
President
Holding Value $93.1k 87,801 shares
Last Trade
Jun 21, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$93.1k 87,801 shares
$1.06
$1.06
Millendo Therapeutics
Millendo Therapeutics MLND
President
Holding Value $120k 113,343 shares
Last Trade
Jan 07, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$2.12k 2,000 shares
$1.06
$1.06
Tempest Therapeutics
Tempest Therapeutics TPST
President
Holding Value $147k 113,343 shares
Last Trade
Jan 07, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$9.56k 2,000 shares
$4.78
$1.30
Millendo Therapeutics
Millendo Therapeutics MLND
President
Holding Value $56.3k 53,100 shares
Last Trade
Jan 04, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$56.3k 53,100 shares
$1.06
$1.06
Tempest Therapeutics
Tempest Therapeutics TPST
President
Holding Value $69k 53,100 shares
Last Trade
Jan 04, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$289k 53,100 shares
$5.45
$1.30
Millendo Therapeutics
Millendo Therapeutics MLND
President
Holding Value $1.06M 1,000,000 shares
Last Trade
Jun 25, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.16M 1,090,301 shares
$1.06
$1.06
Tempest Therapeutics
Tempest Therapeutics TPST
Holding Value $1.3M 1,000,000 shares
Last Trade
Jun 25, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$19.1M 1,201,644 shares
$15.90
$1.30
Chinook Therapeutics
Chinook Therapeutics KDNY
Chief Scientific Officer
Holding Value $1.61M 39,900 shares
Last Trade
Aug 11, 2017 Sale (Open Market)Shares sold on the open market or in a private sale.
$516k 9,088 shares
$56.75
$40.39
Chinook Therapeutics
Chinook Therapeutics KDNY
Chief Scientific Officer
Holding Value $1.98M 48,988 shares
Last Trade
Aug 11, 2017 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$516k 9,088 shares
$56.75
$40.39
Chinook Therapeutics
Chinook Therapeutics KDNY
Chief Scientific Officer
Holding Value $5.1M 126,328 shares
Last Trade
Aug 11, 2017 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$516k 9,088 shares
$56.75
$40.39
Chinook Therapeutics
Chinook Therapeutics KDNY
Chief Scientific Officer
Holding Value $1.61M 39,900 shares
Last Trade
Aug 10, 2017 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.28M 40,912 shares
$55.75
$40.39
Chinook Therapeutics
Chinook Therapeutics KDNY
Chief Scientific Officer
Holding Value $5.47M 135,416 shares
Last Trade
Aug 10, 2017 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.28M 40,912 shares
$55.75
$40.39
Chinook Therapeutics
Chinook Therapeutics KDNY
Chief Scientific Officer
Holding Value $3.26M 80,812 shares
Last Trade
Aug 10, 2017 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.28M 40,912 shares
$55.75
$40.39
Chinook Therapeutics
Chinook Therapeutics KDNY
Chief Scientific Officer
Holding Value $1.79M 44,412 shares
Last Trade
Jul 06, 2017 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$282k 4,512 shares
$62.50
$40.39
Chinook Therapeutics
Chinook Therapeutics KDNY
Chief Scientific Officer
Holding Value $548k 13,571 shares
Last Trade
Jul 06, 2017 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$282k 4,512 shares
$62.50
$40.39
Chinook Therapeutics
Chinook Therapeutics KDNY
Chief Scientific Officer
Holding Value $1.61M 39,900 shares
Last Trade
Jul 06, 2017 Sale (Open Market)Shares sold on the open market or in a private sale.
$282k 4,512 shares
$62.50
$40.39
Chinook Therapeutics
Chinook Therapeutics KDNY
Chief Scientific Officer
Holding Value $1.61M 39,900 shares
Last Trade
Jul 05, 2017 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.93M 33,688 shares
$57.25
$40.39

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up